Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Belén Gaete-Ramírez"'
Autor:
Cristóbal Cerda‐Troncoso, Felipe Grünenwald, Eloísa Arias‐Muñoz, Viviana A. Cavieres, Albano Caceres‐Verschae, Sergio Hernández, Belén Gaete‐Ramírez, Francisca Álvarez‐Astudillo, Rodrigo A. Acuña, Matias Ostrowski, Patricia V. Burgos, Manuel Varas‐Godoy
Publikováno v:
Journal of Extracellular Biology, Vol 3, Iss 6, Pp n/a-n/a (2024)
Abstract Chemoresistance is a common problem in ovarian cancer (OvCa) treatment, where resistant cells, in response to chemotherapy, secrete small extracellular vesicles (sEVs), known as chemo‐sEVs, that transfer resistance to recipient cells. sEVs
Externí odkaz:
https://doaj.org/article/71607ac4471a4ef3a40b3e08d52b8bca
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Advances in our understanding of cancer biology have contributed to generating different treatments to improve the survival of cancer patients. However, although initially most of the therapies are effective, relapse and recurrence occur in a large p
Externí odkaz:
https://doaj.org/article/51e8dc3b190a4d1aa9b86412793c1102
Autor:
Ignacio Niechi, José I. Erices, Diego Carrillo-Beltrán, Atenea Uribe-Ojeda, Ángelo Torres, José Dellis Rocha, Daniel Uribe, María A. Toro, Karla Villalobos-Nova, Belén Gaete-Ramírez, Gabriel Mingo, Gareth I. Owen, Manuel Varas-Godoy, Lilian Jara, Francisco Aguayo, Verónica A. Burzio, Claudia Quezada-Monrás, Julio C. Tapia
Publikováno v:
Cells, Vol 12, Iss 3, p 506 (2023)
Glioblastoma (GBM) is the most common and aggressive type of brain tumor due to its elevated recurrence following treatments. This is mainly mediated by a subpopulation of cells with stemness traits termed glioblastoma stem-like cells (GSCs), which a
Externí odkaz:
https://doaj.org/article/8da72235487e4ae7911a3687cf588995
Autor:
Natalia Barraza-Núñez, Ramón Pérez-Núñez, Belén Gaete-Ramírez, Alejandra Barrios-Garrido, Christian Arriagada, Karen Poksay, Varghese John, Jean-Vianney Barnier, Ana María Cárdenas, Pablo Caviedes
Publikováno v:
Neurotoxicity Research. 41:256-269
Autor:
Cristóbal Cerda-Troncoso, Felipe Grünenwald, Eloísa Arias-Muñoz, Viviana A. Cavieres, Albano Caceres-Verschae, Sergio Hernández, Belén Gaete-Ramírez, Francisca Álvarez-Astudillo, Rodrigo A Acuña, Matias Ostrowski, Patricia V. Burgos, Manuel Varas-Godoy
Ovarian cancer (OvCa) is an aggressive disease usually treated with cisplatin (CDDP)-based therapy. However, among the different types of cancers treated with CDDP, OvCa commonly develops chemoresistance to this treatment. The small extracellular ves
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9048a8ca74556956a5c5dc173a8e14e4
https://doi.org/10.1101/2023.02.03.526974
https://doi.org/10.1101/2023.02.03.526974